First drug to slow Alzheimer’s Disease unveiled in landmark breakthrough

Solanezumab is the first drug shown to target the disease process itself, clearing sticky plaques in the brain which stop the neurons firing

—> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail